Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer-Reference-Cited by-同舟云学术

Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer

Published:2014-10 Issue:10 Volume:16 Page:861-867
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Tibau Ariadna,López-Vilaró Laura,Pérez-Olabarria Maitane,Vázquez Tania,Pons Cristina,Gich Ignasi,Alonso Carmen,Ojeda Belén,Ramón y Cajal Teresa,Lerma Enrique,Barnadas Agustí,Escuin Daniel

Publisher

Elsevier BV

Subject

Cancer Research

Reference45 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

2. The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer;Gogas;Ann Oncol,2003

3. Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer;Estevez;Clin Cancer Res,2004

4. Neoadjuvant taxanes in the treatment of non-metastatic breast cancer: a systematic review;Trudeau;Cancer Treat Rev,2005

5. Defining the benefits of neoadjuvant chemotherapy for breast cancer;Schott;J Clin Oncol,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study;International Journal of Molecular Sciences;2024-04-19

2. THE EFFECT OF TOPOISOMERASE ІІ ALPHA ON THE RESPONSE TO NEOADJUVANT CHEMOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER;Oncology;2023

3. The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer;Histopathology;2022-08-08

4. Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients;Frontiers in Oncology;2021-11-11

5. Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review;Cancers;2021-10-31